These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 24300920)

  • 1. Synthesis and biological evaluation of farnesylthiosalicylamides as potential anti-tumor agents.
    Ling Y; Wang Z; Zhu H; Wang X; Zhang W; Wang X; Chen L; Huang Z; Zhang Y
    Bioorg Med Chem; 2014 Jan; 22(1):374-80. PubMed ID: 24300920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of novel farnesylthiosalicylic acid derivatives for cancer treatment.
    Ling Y; Wang X; Zhu H; Wang Z; Xu C; Wang X; Chen L; Zhang W
    Arch Pharm (Weinheim); 2014 May; 347(5):327-33. PubMed ID: 24435839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid molecule from Farnesylthiosalicylic acid-diamine and phenylpropenoic acid as Ras-related signaling inhibitor with potent antitumor activities.
    Ling Y; Wang Z; Wang X; Li X; Wang X; Zhang W; Dai H; Chen L; Zhang Y
    Chem Biol Drug Des; 2015 Feb; 85(2):145-52. PubMed ID: 25043275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel FTS-diamine/cinnamic acid hybrids inhibit tumor cell proliferation and migration and promote apoptosis via blocking Ras-related signaling in vitro.
    Ling Y; Zhao X; Li X; Wang X; Yang Y; Wang Z; Wang X; Zhang J; Zhang Y
    Cancer Chemother Pharmacol; 2015 Feb; 75(2):381-92. PubMed ID: 25542266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of hybrids from farnesylthiosalicylic acid and hydroxylcinnamic acid with dual inhibitory activities of Ras-related signaling and phosphorylated NF-κB.
    Ling Y; Wang Z; Wang X; Zhao Y; Zhang W; Wang X; Chen L; Huang Z; Zhang Y
    Org Biomol Chem; 2014 Jul; 12(25):4517-30. PubMed ID: 24848877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New derivatives of farnesylthiosalicylic acid (salirasib) for cancer treatment: farnesylthiosalicylamide inhibits tumor growth in nude mice models.
    Goldberg L; Haklai R; Bauer V; Heiss A; Kloog Y
    J Med Chem; 2009 Jan; 52(1):197-205. PubMed ID: 19072665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression signature of human cancer cell lines treated with the ras inhibitor salirasib (S-farnesylthiosalicylic acid).
    Blum R; Elkon R; Yaari S; Zundelevich A; Jacob-Hirsch J; Rechavi G; Shamir R; Kloog Y
    Cancer Res; 2007 Apr; 67(7):3320-8. PubMed ID: 17409441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of nitric oxide-releasing derivatives of farnesylthiosalicylic acid as anti-tumor agents.
    Ling Y; Ye X; Ji H; Zhang Y; Lai Y; Peng S; Tian J
    Bioorg Med Chem; 2010 May; 18(10):3448-56. PubMed ID: 20435479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing FTS (Salirasib) efficiency via combinatorial treatment.
    Wolfson E; Schmukler E; Schokoroy ST; Kloog Y; Pinkas-Kramarski R
    Biol Cell; 2015 May; 107(5):130-43. PubMed ID: 25735913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ras chaperones: new targets for cancer and immunotherapy.
    Kloog Y; Elad-Sfadia G; Haklai R; Mor A
    Enzymes; 2013; 33 Pt A():267-89. PubMed ID: 25033809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybrids from Farnesylthiosalicylic Acid and Hydroxamic Acid as Dual Ras-Related Signaling and Histone Deacetylase (HDAC) Inhibitors: Design, Synthesis and Biological Evaluation.
    Ling Y; Wang X; Wang C; Xu C; Zhang W; Zhang Y; Zhang Y
    ChemMedChem; 2015 Jun; 10(6):971-6. PubMed ID: 25882299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel nitric oxide-releasing derivatives of farnesylthiosalicylic acid: synthesis and evaluation of antihepatocellular carcinoma activity.
    Ling Y; Ye X; Zhang Z; Zhang Y; Lai Y; Ji H; Peng S; Tian J
    J Med Chem; 2011 May; 54(9):3251-9. PubMed ID: 21504204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Ras inhibitor farnesylthiosalicylic acid as a potential therapy for neurofibromatosis type 1.
    Barkan B; Starinsky S; Friedman E; Stein R; Kloog Y
    Clin Cancer Res; 2006 Sep; 12(18):5533-42. PubMed ID: 17000690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Farnesylthiosalicylic acid: inhibition of proliferation and enhancement of apoptosis of hormone-dependent breast cancer cells.
    Santen RJ; Lynch AR; Neal LR; McPherson RA; Yue W
    Anticancer Drugs; 2006 Jan; 17(1):33-40. PubMed ID: 16317288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Ras inhibitor farnesylthiosalicylic acid (Salirasib) disrupts the spatiotemporal localization of active Ras: a potential treatment for cancer.
    Rotblat B; Ehrlich M; Haklai R; Kloog Y
    Methods Enzymol; 2008; 439():467-89. PubMed ID: 18374183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Farnesylthiosalicylic acid sensitizes hepatocarcinoma cells to artemisinin derivatives.
    Wu L; Pang Y; Qin G; Xi G; Wu S; Wang X; Chen T
    PLoS One; 2017; 12(2):e0171840. PubMed ID: 28182780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving Therapeutic Potential of Farnesylthiosalicylic Acid: Tumor Specific Delivery via Conjugation with Heptamethine Cyanine Dye.
    Guan Y; Zhang Y; Xiao L; Li J; Wang JP; Chordia MD; Liu ZQ; Chung LW; Yue W; Pan D
    Mol Pharm; 2017 Jan; 14(1):1-13. PubMed ID: 26992462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ras inhibitor farnesylthiosalicylic acid conjugated with IR783 dye exhibits improved tumor-targeting and altered anti-breast cancer mechanisms in mice.
    Huang QJ; Liao GC; Zhuang XR; Yang ML; Yao JJ; Deng JH; Zhang YM; Wang Y; Qi XX; Pan DF; Guan Y; Huang ZY; Zhang FX; Liu ZQ; Lu LL
    Acta Pharmacol Sin; 2022 Jul; 43(7):1843-1856. PubMed ID: 34845369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Ras antagonist, farnesylthiosalicylic acid (FTS), inhibits experimentally-induced liver cirrhosis in rats.
    Reif S; Weis B; Aeed H; Gana-Weis M; Zaidel L; Avni Y; Romanelli RG; Pinzani M; Kloog Y; Bruck R
    J Hepatol; 1999 Dec; 31(6):1053-61. PubMed ID: 10604579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Farnesylthiosalicylic acid inhibits the growth of human Merkel cell carcinoma in SCID mice.
    Jansen B; Heere-Ress E; Schlagbauer-Wadl H; Halaschek-Wiener J; Waltering S; Moll I; Pehamberger H; Marciano D; Kloog Y; Wolff K
    J Mol Med (Berl); 1999 Nov; 77(11):792-7. PubMed ID: 10619439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.